Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QOL survey in premenopausal breast cancer patients treated with Leuplin SR 11.25 mg
jRCT1080222463
- Sponsor
- Takeda
- Start
- Apr 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of leuprolide in breast cancer, sponsored by Takeda. Primary endpoint: Quality of life over time during Leuplin SR adjuvant therapy.
02
Drugs
leuprolide
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT1080222463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222463.